Success Stories: EB1A Approved for an AI Researcher Advancing Tumor Diagnosis and Responsible Artificial Intelligence Technologies Following RFE

Client’s Testimonial:

“The NAILG immigration team was extremely professional, knowledgeable, and had a robust strategy for case preparation. I appreciate their support in helping to craft a very strong case, with exceptional supporting evidence, analyses, and top arguments. They had a methodical approach and were prompt in their responses to all my queries. Their significant experience showed up in the quality of their prepared petition letter and documents. I would certainly recommend them to anyone looking to traverse a similar immigration path.”

On March 12^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Principal Data Scientist in the field of Artificial Intelligence (Approval Notice).

General Field: Artificial Intelligence

Position at the Time of Case Filing: Principal Data Scientist

Country of Origin: India

State of Residence at the time of filing: Texas

Approval Notice Date: March 12^th, 2025

Processing Time: 4 months (Premium Processing Requested)

Case Summary:

Our client approached North America Immigration Law Group (NAILG) to file an EB1A petition based on his contributions to the application of artificial intelligence in medical diagnostics and AI safety. His multidisciplinary expertise combines digital pathology, deep learning, and algorithmic governance, with a focus on real-world clinical and ethical applications. Through a carefully coordinated legal strategy and detailed documentation, we successfully responded to a Request for Evidence and secured the approval of his EB1A petition.

Pioneering AI for Tumor Detection and AI Governance

The client’s research integrates advanced deep learning models with digital pathology to enhance the detection and classification of tumors, particularly in osteosarcoma. His work bridges computational algorithms with real clinical scenarios, producing highly accurate diagnostic pipelines. In parallel, his research on responsible AI addresses critical challenges related to fairness, risk mitigation, and the secure deployment of generative models in corporate environments.

By developing data-centric and explainable AI systems, he contributes to both healthcare innovation and the global discourse on AI governance and safety.

His Scientific Work Has Earned Broad Recognition

5 peer-reviewed journal articles and several technical papers and abstracts
Over 200 citations in AI, medical imaging, and healthcare informatics
More than 20 peer reviews for high-impact journals and conferences
Multiple articles have been adopted by independent researchers across the U.S., Europe, Asia, and Australia

His work has been featured in journals like PLOS ONE and proceedings from major symposia. It has also been cited in projects funded by prominent global agencies, supporting next-generation AI deployment in healthcare.

Here is a compelling excerpt from one of the recommendation letters that highlights how the client’s research benefits the United States:

“[Client’s] advances digital pathology and cancer diagnostics through his work in artificial intelligence. His sophisticated mechanism for processing osteosarcoma images and his findings on automated cellular analysis and tumor characterization serve as a testament to his ability to drive further progress in cancer research and personalized treatment strategies.”

Notable Scientific Contributions Include:

The client co-developed a digital pathology system capable of detecting osteosarcoma tumor regions from histology slides with clinical-grade accuracy. He also proposed a framework for evaluating risks and vulnerabilities in generative AI systems, offering tools now used in the assessment of safety and fairness for large language models. Additionally, his early work introduced a model for predicting recurrence in oral squamous cell carcinoma, now cited in diagnostic workflows across several international institutions.

These contributions have had a direct impact on both translational medicine and the ethical deployment of machine learning systems.

NAILG’s Strategic Approach: Establishing Extraordinary Ability

We presented a comprehensive EB1A petition demonstrating the client’s:

Original scientific contributions of major significance in AI and biomedical imaging
Record of peer-reviewed publications and international citations
Documented participation as a reviewer for leading scientific venues
Influence evidenced by the adoption of his work in over 30 countries and across sectors

The petition included expert recommendation letters, many from independent researchers highlighting his originality, scientific rigor, and continued ability to benefit the United States in both AI innovation and ethical research leadership.

This case was approved following a well-addressed RFE and underscores the strength of the client’s portfolio in a field of growing national interest. We are proud to support exceptional scientists and engineers like this client as they contribute to advancements that shape global AI standards and healthcare technologies.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.